AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32780138 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion thresholds (n=521)
Number of subjects: 1013
Study 35094914 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated whole-breast irradiation (HF-WBI)
Number of subjects: 718
Study 35094914 — intervention group
Group type: COMPARATOR
Intervention: Conventionally fractionated whole-breast irradiation (CF-WBI)
Number of subjects: 718
Study 34538253 — intervention group
Group type: EXPERIMENTAL
Intervention: LGO-S (Let's Get Organized) intervention for 10 weeks
Number of subjects: 104
Study 34538253 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (individual occupational therapy)
Number of subjects: 104
Study 32853384 — intervention group
Group type: EXPERIMENTAL
Intervention: Lattice radiation therapy (LRT) with a dose of 24 Gy in three fractions, followed by conventionally fractionated external beam irradiation to 44.28 Gy
Number of subjects: 10
Study 33338415 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1000 mg) administered via intramuscular injection at baseline, 6 weeks, and then every 3 months for 2 years.
Number of subjects: 1007
Study 33338415 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered via intramuscular injection at baseline, 6 weeks, and then every 3 months for 2 years.
Number of subjects: 1007
Study 33338415 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone undecanoate (1000 mg) administered via intramuscular injection.
Number of subjects: 1007
Study 33338415 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered via intramuscular injection.
Number of subjects: 1007
Study 32147751 — intervention group
Group type: EXPERIMENTAL
Intervention: MOP1 group received 3 MOPs on the buccal surface of alveolar bone
Number of subjects: 28
Study 32147751 — intervention group
Group type: EXPERIMENTAL
Intervention: MOP2 group received 3 buccal MOPs and 3 palatal MOPs
Number of subjects: 28
Study 32147751 — intervention group
Group type: COMPARATOR
Intervention: Control side (no MOPs)
Number of subjects: 28
Study 34328029 — intervention group
Group type: EXPERIMENTAL
Intervention: CoYoT1 Clinic (TH+VGA; n=23)
Number of subjects: 53
Study 34328029 — intervention group
Group type: COMPARATOR
Intervention: TH-only (n=35)
Number of subjects: 53
Study 33930663 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 55
Study 33930663 — intervention group
Group type: COMPARATOR
Intervention: Services as usual (SAU)
Number of subjects: 55
Study 33196446 — intervention group
Group type: EXPERIMENTAL
Intervention: CT‐QFR
Number of subjects: 231
Study 33196446 — intervention group
Group type: COMPARATOR
Intervention: MPS
Number of subjects: 231
Study 33196446 — intervention group
Group type: COMPARATOR
Intervention: CMR
Number of subjects: 231
Study 32134956 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX) 50 mg daily
Number of subjects: 155
Study 32134956 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study 32134956 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (NTX)
Number of subjects: 155
Study 35381069 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily prednisone (0.75 mg/kg)
Number of subjects: 196
Study 35381069 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily deflazacort (0.90 mg/kg)
Number of subjects: 196
Study 35381069 — intervention group
Group type: COMPARATOR
Intervention: Intermittent prednisone (0.75 mg/kg for 10 days on and then 10 days off)
Number of subjects: 196
Study 34485814 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 3649
Study 34485814 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3649
Study 32587591 — intervention group
Group type: EXPERIMENTAL
Intervention: PD-1/PD-L1 inhibitors
Number of subjects: 308
Study 35493119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg plus standard of care (SOC)
Number of subjects: 46
Study 35493119 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus standard of care (SOC)
Number of subjects: 46
Study 35493119 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibrutinib plus SOC
Number of subjects: 46
Study 35493119 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus SOC
Number of subjects: 46
Study 33026598 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation
Number of subjects: 0
Study 33026598 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 33567080 — intervention group
Group type: EXPERIMENTAL
Intervention: Occipitoatlantal decompression (OAD)
Number of subjects: 30
Study 33567080 — intervention group
Group type: COMPARATOR
Intervention: Sham touch
Number of subjects: 30
Study 32664602 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity levels
Number of subjects: 414
Study 32664602 — intervention group
Group type: EXPERIMENTAL
Intervention: At-risk groups (female, overweight/obese, non-smoking, poor fitness perceptions, low fruit/vegetable consumption, excess screen-based sedentariness)
Number of subjects: 414
Study 32664602 — intervention group
Group type: COMPARATOR
Intervention: UK National Physical Activity Guidelines
Number of subjects: 414
Study 35219505 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic trials in long-term care
Number of subjects: 0
Study 33823506 — intervention group
Group type: EXPERIMENTAL
Intervention: Visually guided saccades (VGSs)
Number of subjects: 50
Study 33823506 — intervention group
Group type: EXPERIMENTAL
Intervention: Contralateral VGSs relative to the side of the more severely affected striatum
Number of subjects: 50
Study 33823506 — intervention group
Group type: EXPERIMENTAL
Intervention: Dopamine transporter (DAT) SPECT specific binding ratio (SBR)
Number of subjects: 50
Study 33823506 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (NCs)
Number of subjects: 50
Study 32866619 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (ET; 3 days/week, 45 minutes/day for 8 weeks)
Number of subjects: 40
Study 32866619 — intervention group
Group type: COMPARATOR
Intervention: Non-exercise control group (CON)
Number of subjects: 40
Study 32866619 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (ET)
Number of subjects: 40
Study 35544293 — intervention group
Group type: EXPERIMENTAL
Intervention: High social presence group
Number of subjects: 206
Study 35544293 — intervention group
Group type: COMPARATOR
Intervention: Low social presence group
Number of subjects: 206
Study 32728881 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein meal (En% F/C/P: 10.6, 51.5, 36.9)
Number of subjects: 18
Study 32728881 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate meal (En% F/C/P: 9.6, 81.5, 8.6)
Number of subjects: 18
Study 32728881 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal (En% F/C/P: 52.3, 39.2, 8.0)
Number of subjects: 18
Study 32728881 — intervention group
Group type: COMPARATOR
Intervention: All meals
Number of subjects: 18
Study 35662050 — intervention group
Group type: EXPERIMENTAL
Intervention: iCanQuit
Number of subjects: 348
Study 35662050 — intervention group
Group type: COMPARATOR
Intervention: QuitGuide
Number of subjects: 348
Study 32989597 — intervention group
Group type: EXPERIMENTAL
Intervention: BioRootTM RCS (Septodont) with single-cone technique
Number of subjects: 69
Study 32989597 — intervention group
Group type: COMPARATOR
Intervention: Gutta-percha and zinc oxide-eugenol sealer (ZOE) with warm vertical compaction
Number of subjects: 69
Study 33159336 — intervention group
Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme (NFPP‐SH) + Treatment as Usual (TAU)
Number of subjects: 52
Study 33159336 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 52
Study 32929756 — intervention group
Group type: EXPERIMENTAL
Intervention: Copula-based construction of the joint density of the marker and the outcome using Gaussian copula and customized margin for the marker.
Number of subjects: 0
Study 32929756 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimation using maximum likelihood and resampling-based methods.
Number of subjects: 0
Study 34636914 — intervention group
Group type: EXPERIMENTAL
Intervention: 3A-HBV (10 μg)
Number of subjects: 2838
Study 36380220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis with 0 mg CBD (0:1 CBD:THC)
Number of subjects: 46
Study 36380220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis with 10 mg CBD (1:1 CBD:THC)
Number of subjects: 46
Study 36380220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis with 20 mg CBD (2:1 CBD:THC)
Number of subjects: 46
Study 36380220 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabis with 30 mg CBD (3:1 CBD:THC)
Number of subjects: 46
Study 33988760 — intervention group
Group type: EXPERIMENTAL
Intervention: AcroQoL questionnaire
Number of subjects: 424
Study 33988760 — intervention group
Group type: EXPERIMENTAL
Intervention: EQ‐5D‐5L index score
Number of subjects: 424
Study 33988760 — intervention group
Group type: EXPERIMENTAL
Intervention: OLS model using AcroQoL scores
Number of subjects: 424
Study 33356790 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice facilitation intervention
Number of subjects: 6
Study 34444958 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal lifestyle intervention (low-GI diet and physical activity)
Number of subjects: 434
Study 34444958 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 434
Study 34444958 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal lifestyle intervention
Number of subjects: 434
Study 32054315 — intervention group
Group type: EXPERIMENTAL
Intervention: Pivotal response treatment package
Number of subjects: 48
Study 32054315 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual intervention services)
Number of subjects: 48
Study 35130850 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium hyaluronate (0.1%) combined with rhEGF (20 μg/ml)
Number of subjects: 106
Study 35130850 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate (0.1%)
Number of subjects: 106
Study 33930388 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute stress task (ScanSTRESS‐C; n = 40)
Number of subjects: 81
Study 33930388 — intervention group
Group type: COMPARATOR
Intervention: Control condition (n = 41)
Number of subjects: 81
Study 33930388 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Emotion Regulation Task (CERT) with distraction and reappraisal
Number of subjects: 81
Study 33930388 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Emotion Regulation Task (CERT)
Number of subjects: 81
Study 34446491 — intervention group
Group type: EXPERIMENTAL
Intervention: Gallstone disease (GD) cohort
Number of subjects: 343300
Study 34446491 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-cholecystectomy patients with GD
Number of subjects: 343300
Study 34446491 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecystectomy patients with GD
Number of subjects: 343300
Study 34446491 — intervention group
Group type: COMPARATOR
Intervention: Non-GD cohort (control)
Number of subjects: 343300
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 75 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 70 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 65 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 60 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-weighted-average-mean arterial pressure below 55 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 75 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 70 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 65 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 60 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative-time-below 55 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean arterial pressure less than 65 mm Hg
Number of subjects: 273
Study 32618694 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean arterial pressure less than 60 mm Hg
Number of subjects: 273
Study 36232040 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively challenging physical activity intervention
Number of subjects: 99
Study 36232040 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 99
Study 32236916 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternative distinct naming strategy
Number of subjects: 25
Study 32236916 — intervention group
Group type: COMPARATOR
Intervention: Standard distinct naming strategy
Number of subjects: 25
Study 36121160 — intervention group
Group type: EXPERIMENTAL
Intervention: Supine position
Number of subjects: 14
Study 36121160 — intervention group
Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 14
Study 35177807 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate diet (60% carbohydrate as a proportion of total energy, n = 10)
Number of subjects: 27
Study 35177807 — intervention group
Group type: COMPARATOR
Intervention: Moderate-carbohydrate diet (40%, n = 8)
Number of subjects: 27
Study 35177807 — intervention group
Group type: COMPARATOR
Intervention: Low-carbohydrate diet (20%, n = 9)
Number of subjects: 27
Study 35340239 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic dietary education combined with multidisciplinary nursing
Number of subjects: 90
Study 35340239 — intervention group
Group type: COMPARATOR
Intervention: Conventional intervention (routine group)
Number of subjects: 90
Study 34984483 — intervention group
Group type: EXPERIMENTAL
Intervention: Taperloc Complete full profile (TCFP)
Number of subjects: 100
Study 34984483 — intervention group
Group type: EXPERIMENTAL
Intervention: Taperloc Complete reduced distal (TCRD)
Number of subjects: 100
Study 34984483 — intervention group
Group type: EXPERIMENTAL
Intervention: Taperloc full profile (TFP)
Number of subjects: 100
Study 34984483 — intervention group
Group type: EXPERIMENTAL
Intervention: Taperloc reduced distal (TRD)
Number of subjects: 100
Study 34100952 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual representation of patients' past culture data
Number of subjects: 273
Study 34100952 — intervention group
Group type: COMPARATOR
Intervention: Standard EHR functionality (control)
Number of subjects: 273
Study 35319001 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength endurance training
Number of subjects: 95
Study 35319001 — intervention group
Group type: EXPERIMENTAL
Intervention: Power training
Number of subjects: 95
Study 35319001 — intervention group
Group type: EXPERIMENTAL
Intervention: Absolute strength training
Number of subjects: 95
Study 35319001 — intervention group
Group type: EXPERIMENTAL
Intervention: Relative strength training
Number of subjects: 95
Study 35319001 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 95
Study 35319001 — intervention group
Group type: EXPERIMENTAL
Intervention: Detraining after resistance training
Number of subjects: 95
Study 32202507 — intervention group
Group type: EXPERIMENTAL
Intervention: E-learning group (EG)
Number of subjects: 44
Study 32202507 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 35856287 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation (NMES) plus standard of care (SOC)
Number of subjects: 19
Study 35856287 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 19
Study 33649872 — intervention group
Group type: COMPARATOR
Intervention: 0% PKC inclusion
Number of subjects: 40
Study 33649872 — intervention group
Group type: EXPERIMENTAL
Intervention: 8% PKC inclusion
Number of subjects: 40
Study 33649872 — intervention group
Group type: EXPERIMENTAL
Intervention: 16% PKC inclusion
Number of subjects: 40
Study 33649872 — intervention group
Group type: EXPERIMENTAL
Intervention: 24% PKC inclusion
Number of subjects: 40
Study 36443712 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical Behavioral Therapy-based group treatment (DBT-bGT)
Number of subjects: 121
Study 36443712 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 121
Study 36443712 — intervention group
Group type: EXPERIMENTAL
Intervention: DBT-bGT
Number of subjects: 121
Study 33930527 — intervention group
Group type: EXPERIMENTAL
Intervention: New treatment (hazard ratio equals 0.7)
Number of subjects: 0
Study 33930527 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (null hypothesis: hazard ratio equals 1)
Number of subjects: 0
Study 32525761 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic elastomeric fabric orthoses (compression shorts) with standard postnatal care
Number of subjects: 51
Study 32525761 — intervention group
Group type: COMPARATOR
Intervention: Standard postnatal care alone (comparison group)
Number of subjects: 51
Study 32525761 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 51
Study 35470717 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guided distal radial artery cannulation (group D)
Number of subjects: 200
Study 35470717 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guided conventional radial artery cannulation (group W)
Number of subjects: 200
Study 34975830 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C supplementation (500 mg daily for 14 days)
Number of subjects: 120
Study 33539242 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual teaching intervention
Number of subjects: 200
Study 33539242 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 200
Study 35796695 — intervention group
Group type: EXPERIMENTAL
Intervention: Eriomin (200 mg/d for 12 weeks)
Number of subjects: 30
Study 35796695 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 34155073 — intervention group
Group type: EXPERIMENTAL
Intervention: Usual care plus the GRRAND intervention (individualised rehabilitation programme)
Number of subjects: 60
Study 34155073 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 60
Study 35367955 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy with a Well‐Being focus
Number of subjects: 85
Study 35367955 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness Based Cognitive Therapy
Number of subjects: 85
Study 34310552 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral skull base approach for resection of vestibular schwannoma and postoperative monitoring
Number of subjects: 200
Study 32691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 180 μm
Number of subjects: 1143
Study 32691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 190 μm
Number of subjects: 1143
Study 32691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 200 μm
Number of subjects: 1143
Study 32691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter 210 μm
Number of subjects: 1143
Study 32691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) with diameter over 220 μm
Number of subjects: 1143
Study 32691193 — intervention group
Group type: EXPERIMENTAL
Intervention: Day 7 blastocyst (SVBT) hatched
Number of subjects: 1143
Study 32691193 — intervention group
Group type: COMPARATOR
Intervention: Day 2 single-embryo transfer (SET)
Number of subjects: 1143
Study 35874984 — intervention group
Group type: EXPERIMENTAL
Intervention: Climate change affected scenario (CCA)
Number of subjects: 311
Study 35874984 — intervention group
Group type: COMPARATOR
Intervention: Climate change unaffected scenario (CCU)
Number of subjects: 311
Study 35874984 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher affective valence
Number of subjects: 311
Study 34621327 — intervention group
Group type: EXPERIMENTAL
Intervention: Mifepristone combined with misoprostol
Number of subjects: 95
Study 34621327 — intervention group
Group type: COMPARATOR
Intervention: Diethylstilbestrol combined with oxytocin
Number of subjects: 95
Study 35861792 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 150 mg
Number of subjects: 32
Study 35861792 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 300 mg
Number of subjects: 32
Study 35861792 — intervention group
Group type: EXPERIMENTAL
Intervention: CBD 600 mg
Number of subjects: 32
Study 35861792 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 33727998 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative chemical splanchnicectomy of celiac ganglions
Number of subjects: 0
Study 33727998 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 34838891 — intervention group
Group type: EXPERIMENTAL
Intervention: RT quality assurance (RTQA) practices mandated in trial protocol
Number of subjects: 42
Study 34838891 — intervention group
Group type: EXPERIMENTAL
Intervention: Institutional credentialing
Number of subjects: 42
Study 34838891 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol deviation outcomes published
Number of subjects: 42
Study 34838891 — intervention group
Group type: COMPARATOR
Intervention: Advanced radiation techniques (IMRT, VMAT, SRS, SBRT)
Number of subjects: 42
Study 34838891 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting protocol deviation outcomes
Number of subjects: 42
Study 32711663 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia exposure procedure
Number of subjects: 36
Study 32711663 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 36
Study 32711663 — intervention group
Group type: COMPARATOR
Intervention: Waiting List Group
Number of subjects: 36
Study 33629525 — intervention group
Group type: EXPERIMENTAL
Intervention: Trabeculectomy (TE)
Number of subjects: 70
Study 33629525 — intervention group
Group type: COMPARATOR
Intervention: Baerveldt implant (BGI)
Number of subjects: 70
Study 34165523 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced-intensity chemotherapy with oxaliplatin and capecitabine
Number of subjects: 0